These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 16433181)

  • 41. Viewpoint: challenges in our understanding of neuroleptic induced parkinsonism.
    Friedman JH
    Parkinsonism Relat Disord; 2014 Dec; 20(12):1325-8. PubMed ID: 25456826
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Neuroleptic treatment effect on mitochondrial electron transport chain: peripheral blood mononuclear cells analysis in psychotic patients.
    Casademont J; Garrabou G; Miró O; López S; Pons A; Bernardo M; Cardellach F
    J Clin Psychopharmacol; 2007 Jun; 27(3):284-8. PubMed ID: 17502776
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparing three screening tools for drug-induced parkinsonism in patients with advanced schizophrenia: a pilot study.
    Blanchet PJ; Normandeau L; Rompré PH
    Schizophr Res; 2012 May; 137(1-3):230-3. PubMed ID: 22309978
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Failure of recognition of drug-induced parkinsonism in the elderly.
    Esper CD; Factor SA
    Mov Disord; 2008 Feb; 23(3):401-4. PubMed ID: 18067180
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Electroconvulsive therapy in neuroleptic-induced parkinsonism.
    Goswami U; Dutta S; Kuruvilla K; Papp E; Perenyi A
    Biol Psychiatry; 1989 Jul; 26(3):234-8. PubMed ID: 2568133
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Incidence and predictors of drug-induced parkinsonism in older psychiatric patients treated with very low doses of neuroleptics.
    Caligiuri MP; Lacro JP; Jeste DV
    J Clin Psychopharmacol; 1999 Aug; 19(4):322-8. PubMed ID: 10440459
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Liverpool University Neuroleptic Side-Effect Rating Scale (LUNSERS) as a subjective measure of drug-induced parkinsonism and akathisia.
    Jung HY; Kim JH; Ahn YM; Kim SC; Hwang SS; Kim YS
    Hum Psychopharmacol; 2005 Jan; 20(1):41-5. PubMed ID: 15565639
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Motoric neurological soft signs and psychopathological symptoms in schizophrenic psychoses.
    Jahn T; Hubmann W; Karr M; Mohr F; Schlenker R; Heidenreich T; Cohen R; Schröder J
    Psychiatry Res; 2006 Jun; 142(2-3):191-9. PubMed ID: 16650902
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Neuroleptic drug exposure and treatment of parkinsonism in the elderly: a case-control study.
    Avorn J; Bohn RL; Mogun H; Gurwitz JH; Monane M; Everitt D; Walker A
    Am J Med; 1995 Jul; 99(1):48-54. PubMed ID: 7598142
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Developmental reflexes and parkinsonism in mentally disturbed aged: a 1-year follow-up study].
    de Groot MC; Trommel J; Gips CH
    Gerontologie; 1980 May; 11(2):144-6. PubMed ID: 7399348
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Quetiapine-induced neuroleptic malignant syndrome in dementia with Lewy bodies: a case report.
    Kobayashi A; Kawanishi C; Matsumura T; Kato D; Furukawa R; Kishida I; Hirayasu Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug; 30(6):1170-2. PubMed ID: 16682107
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The impact of omega-3 fatty acids, vitamins E and C supplementation on treatment outcome and side effects in schizophrenia patients treated with haloperidol: an open-label pilot study.
    Sivrioglu EY; Kirli S; Sipahioglu D; Gursoy B; Sarandöl E
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Oct; 31(7):1493-9. PubMed ID: 17688987
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Drug-induced Parkinson`s disease. A clinical review.
    Bohlega SA; Al-Foghom NB
    Neurosciences (Riyadh); 2013 Jul; 18(3):215-21. PubMed ID: 23887211
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Drug-induced parkinsonism].
    Kuzuhara S
    Ryoikibetsu Shokogun Shirizu; 1999; (27 Pt 2):29-31. PubMed ID: 10434583
    [No Abstract]   [Full Text] [Related]  

  • 55. Quantitative measurement of handwriting in the assessment of drug-induced parkinsonism.
    Caligiuri MP; Teulings HL; Filoteo JV; Song D; Lohr JB
    Hum Mov Sci; 2006 Oct; 25(4-5):510-22. PubMed ID: 16647772
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Increased suicidal risk among smoking schizophrenia patients.
    Iancu I; Sapir AP; Shaked G; Poreh A; Dannon PN; Chelben J; Kotler M
    Clin Neuropharmacol; 2006; 29(4):230-7. PubMed ID: 16855425
    [TBL] [Abstract][Full Text] [Related]  

  • 57. An open, randomized, comparative study of efficacy and safety of risperidone and haloperidol in schizophrenia.
    Tamrakar SM; Nepal MK; Koirala NR; Sharma VD; Gurung CK; Adhikari SR
    Kathmandu Univ Med J (KUMJ); 2006; 4(2):152-60. PubMed ID: 18603890
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Placebo-level incidence of extrapyramidal symptoms (EPS) with quetiapine in controlled studies of patients with bipolar mania.
    Nasrallah HA; Brecher M; Paulsson B
    Bipolar Disord; 2006 Oct; 8(5 Pt 1):467-74. PubMed ID: 17042884
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Association of the RGS2 gene with extrapyramidal symptoms induced by treatment with antipsychotic medication.
    Greenbaum L; Strous RD; Kanyas K; Merbl Y; Horowitz A; Karni O; Katz E; Kotler M; Olender T; Deshpande SN; Lancet D; Ben-Asher E; Lerer B
    Pharmacogenet Genomics; 2007 Jul; 17(7):519-28. PubMed ID: 17558307
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sexual dysfunction in psychiatric inpatients the role of antipsychotic medication.
    Westheide J; Cohen S; Bender S; Cooper-Mahkorn D; Erfurth A; Gastpar M; Huber TJ; Maier W; Murafi A; Rothermund M; Signerski J; Sträter B; Teusch L; Weig W; Welling A; Kühn KU
    Pharmacopsychiatry; 2007 Jul; 40(4):140-5. PubMed ID: 17694475
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.